All news

Elevance Health stock hits 52-week high of $436.30

Alpha Vantage · Investing.com UK · · AI-summarised by FinFlash

Elevance Health Inc. (ELV) reached a new 52-week high of $436.30, with the stock trading at $436.98. Shares are up 23.87% over the past year and 35.85% over six months. Guggenheim and Cantor Fitzgerald have maintained positive ratings and price targets. For investors, the milestone signals sustained confidence in the insurer's performance and continued analyst support.

Read original source

ELV company analysis

Understand the context

Published information may change. Summaries can contain errors; check the original source. Educational information only, not investment advice.